Related Experiment Videos

Functional interaction between a novel protein phosphatase 2A regulatory subunit, PR59, and the

P M Voorhoeve1, E M Hijmans, R Bernards

  • 1Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam.

Oncogene
|February 2, 1999
PubMed

Insights

Researchers discovered a new Protein Phosphatase 2A (PP2A) subunit, PR59, which dephosphorylates p107. This dephosphorylation inhibits cell proliferation, highlighting PP2A

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Retinoblastoma family proteins are key cell cycle inhibitors.
  • Phosphorylation by cyclin-dependent kinases inactivates these proteins.
  • Mechanisms of retinoblastoma protein dephosphorylation remain largely unknown.

Purpose of the Study:

  • To investigate the dephosphorylation of retinoblastoma-family proteins.
  • To identify novel regulatory subunits of Protein Phosphatase 2A (PP2A) involved in this process.

Main Methods:

  • Isolation of a novel PP2A regulatory subunit (PR59) by its association with p107.
  • Co-immunoprecipitation assays to confirm PR59's association with the PP2A catalytic subunit.
  • In vivo studies to assess PR59's interaction with p107 and pRb.
  • Analysis of p107 and pRb phosphorylation status upon PR59 expression.
  • Cell proliferation assays to evaluate the impact of PR59 on cell cycle progression.

Main Results:

  • A novel PP2A regulatory subunit, PR59, was identified.
  • PR59 specifically associates with p107 and dephosphorylates it.
  • PR59 expression leads to G1 cell cycle arrest, inhibiting proliferation.
  • PR59 differs functionally and in expression from the known PP2A subunit PR72.

Conclusions:

  • PR59 is a functional component of PP2A holo-enzymes.
  • Distinct PP2A regulatory subunits, like PR59, target the catalytic subunit to specific substrates.
  • PP2A, through PR59, plays a significant role in regulating p107 activity and cell proliferation.

Related Concept Videos